Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Share this article
Open Access Highly Access

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Alexandra M Pietersen†, Hugo M Horlings†, Michael Hauptmann, Anita Langerød, Abderrahim Ajouaou, Paulien Cornelissen-Steijger, Lodewijk F Wessels, Jos Jonkers, Marc J Vijver and Maarten van Lohuizen*

Breast Cancer Research 2008, 10:R109 doi:10.1186/bcr2214

Accesses  

  • Last 30 days: 163 accesses
  • Last 365 days: 1666 accesses
  • All time: 9052 accesses

Cited by

BioMed Central: 2 citations

Editorial   Free Highly Accessed

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer

Max S Wicha Breast Cancer Research 2009, 11:108 (23 September 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access Highly Accessed

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Julian Puppe, Rinske Drost, Xiaoling Liu, Simon A Joosse, Bastiaan Evers, Paulien Cornelissen-Steijger, Petra Nederlof, Qiang Yu, Jos Jonkers, Maarten van Lohuizen, Alexandra M Pietersen Breast Cancer Research 2009, 11:R63 (26 August 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations